There are different types of targeted therapy
Stress can impact immune function and may contribute to the development or exacerbation of autoimmune responses
Cardiovascular Outcomes This section reviews current evidence regarding GLP-1 RAs effects on MACE, PAD, CAD, HF, blood pressure, and AF, with detailed findings of trials and meta-analyses discussed in Tables 1 and 2 Major Adverse Cardiac Events Among Patients with T2DM Strong evidence supports using GLP-1 RAs to reduce MACE among patients with T2DM and established CVD
Decreased bone density : As bones become weaker, this heightens the risk of fractures and osteoporosis
However, recent studies suggest a shift from this traditional classification toward the identification of distinct mitochondrial phenotypes in ASD
Lafferty RA, Flatt PR, Irwin N (2023) GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy